GSK Investigational Site

Lüneburg, Lower Saxony 21339

0 studies enrolling now · 5 studies all time

What they study most

Alzheimer's Disease, Diabetes Mellitus, Type 2

Studies at this site

• A New Oral Treatment For Type II Diabetes Mellitus — Completed
• Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide — Completed
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease — Completed
• Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers — Stopped early
• Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive — Completed